期刊文献+

荧光PCR法半定量肺炎支原体的研究 被引量:2

Study on semi-quantitation of Mycoplasma pneumoniae by fluorescence quantitative PCR
原文传递
导出
摘要 目的:研究MPLI(肺炎支原体载量指数)的参考范围,探讨其在儿童肺炎支原体(MP)感染诊断中的应用价值。方法:2008年3月末采集3-6岁健康儿童咽拭子标本128例,采用FQ-PCR法分别检测MP-DNA和Hactin-DNA后计算MPLI值:MPLI=-lg(MP-DNA拷贝量/Hactin-DNA拷贝量),然后算出MPLI的参考范围(P5)。2008年3月-7月于我院儿科采集临床患儿咽拭子标本110例及其双份血清,分别用FQ-PCR法和MP-IgM法检测咽拭子和血清标本。以单次或双次MP-IgM型抗体阳性作为判定MP感染的标准,算出各种方法的SEN、SPE、+PV、-PV,并制作MPLI的ROC曲线。比较P5与ROC曲线所得界值的优劣。结果:ROC所得MPLI界值优于128例健康儿童MPLI的P5界值,所以,3-6岁儿童咽拭子MPLI的参考范围为:≥5.90。根据金标准,110例标本中有26例确诊为MP感染;以此为基础,一次MP-IgM法的SEN、SPE、+PV、-PV分别为73.1%、100.0%、100.0%和92.3%;两次MP-IgM法的均为100.0%;单一FQ-PCR法的依次为26.9%、95.2%、63.6%和80.8%;MPLI的依次为26.9%、98.8%、87.5%和81.4%。结论:(1)单一FQ-PCR法测定MP-DNA的弱点很明显:假阳性率高,主要由于未对临床标本进行"标准化",故而大大限制了其在临床上的大规模应用。(2)MPLI的优点在于对临床标本进行了"标准化",充分弥补了单一FQ-PCR法假阳性率高的弱点,结果更具说服力;MPLI能早于MP-IgM法诊断MP急性感染。(3)在允许(如经济状况等)的情况下,MPLI和MP-IgM法的结合将会是很好的组合,既能早期发现MP急性感染,又能准确诊断MP感染的恢复(早)期状态。 Objective:To investigate the reference range of MPLI(Mycoplasma pneumoniae load index) and its usefulness in the diagnosis of Mycoplasma pneumoniae(MP) infection in children. Methods: 128 throat swabs were collected from 128 healthy children aged between 3 and 6 years at the end of March 2008. Fluorescence quantitative PCR( FQ - PCR) assay was used to ana- lyze MP- DNA and human actin- DNA( H actin -DNA) for those swabs. MPLI was then calculated: MPLI = -lg( MP- DNA copies/H actin - DNA copies), followed by the calculation of its reference rage( P5 )- 110 throat swabs were collected with paired sera from the department of pediatry in our hospital from March to July 2008. The former FQ - PCR assay was used to analyze throat swabs, MP - IgM assay for the sera. It was made a gold standard for MP infection that MP - IgM was positive once or twice, on which sensitivity( SEN), specificity( SPE), positive predictive value( + PV), negative predictive value (-PV) and receiver operator characteristic curve (ROC) for MPLI were made based. P5 was compared with the cut -off from ROC. Results:The cut - off from ROC was better than that from P5 of 128 normal samples. Thus, the reference range of MPLI was determined as above 5.90 for children aged 3 to 6 years. 26 children were diagnosed MP infection among those 110 samples according to the gold standard. Then the values of SEN, SPE, + PV, -PV were 73. 1%, 100.0%, 100.0% and 92.3% for a single MP- IgM, all 100. 0% for double MP - IgM respectively. Such were 26.9%, 95.2%, 63. 6% and 80. 8% for FQ - PCR alone, 26. 9%, 98. 8%, 87.5% and 81.4% for MPLI respectively. Conclusion: (1) FQ -PCR assay alone for MP- DNA is limited for its low SEN and high false positive rate, mainly due to non - standarization of clinical samples, which well restricts its clinical large - scale application. (2) The advantage of MPLI lies in its standarization of clinical samples, which makes up the limitation of high false positive rate for FQ - PCR alone and makes the results more persuasive. MPLI could help diagnose acute MP infection earlier than MP- IgM. (3) Under possible conditions( such as economy), MPLI and MP- DNA will be a good combination: it can not only detect acute MP infection earlier, but also help diagnose (early) convalescent state of MP infection.
出处 《中国卫生检验杂志》 CAS 2009年第4期755-760,共6页 Chinese Journal of Health Laboratory Technology
关键词 肺炎支原体 儿童 感染 FQ-PCR Mycoplasma pneumoniae Children Infection Fluorescence quantitative PCR
  • 相关文献

参考文献22

  • 1Lieberman D, Schlaeffer F, Lieberman D, et al. Mycoplasma pneumoniae community -aquired pneumonia: a review of 101 hospitalized adult patients [ J ]. Respiration, 1996, 63 : 261 - 266.
  • 2Gomez J, Banos V, Ruiz - Gomez J,et al. Prospective study of epidemiology and prognostic factors in community -aquired pneumonia[ J ]. Eur J Clin Microbiol Infect Dis, 1996, 15:556 -560.
  • 3Talkington DF, Waites KB, Schwartz SB, et al. Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis and epidemiology of human Mycoplasma pneumoniae infections. Scheld WM, Craig WA, Hughes JM, Emerging infections[ J]. American Society for Microbiology, Washington, DC ,2001 : 57 - 84.
  • 4Clyde WA Jr. Clinical overview of typical Mycoplasma pneumoniae infections[J]. Clin Infect Dis, 1993, 17(suppl 1 ) :32 -36.
  • 5Denny FW, Clyde WA Jr, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control [J]. J Infect Dis, 1971, 123:74 -92.
  • 6Bochud P - Y, Moser F, Erard P,et al. Community - aquired pneumonia. A prospective outpatient study[ J ]. Medicine, 2001, 80:75 -87.
  • 7Taylor - Robinson D. Infections due to species of mycoplasma and ureaplasma : an update[ J ]. Clin Infect Dis, 1996, 23:671 - 684.
  • 8Waris ME, Toikka P, Saarinen T, et aL Diagnosis of Mycoplasma pneumoniae pneumonia in children [ J ]. J Clin Microbiol, 1998, 36 :3155 - 3159.
  • 9Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection [ J ]. Clin Microbiol Infect, 2003, 9 : 263 - 273.
  • 10R Nir - Paz, A Michael - Gayego, M Ron, et al. Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection [ J ]. Clin Microbiol Infect, 2006,12 : 685 - 688.

共引文献19

同被引文献33

引证文献2

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部